Australia markets open in 5 hours 14 minutes

BioCryst Pharmaceuticals Inc (BO1.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
4.8130-0.0090 (-0.19%)
As of 02:36PM CEST. Market open.
Full screen
Previous close4.8220
Open4.8250
Bid4.9160 x 250000
Ask4.9710 x 250000
Day's range4.8130 - 4.8250
52-week range3.7640 - 8.1960
Volume0
Avg. volume142
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript

    BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q1 2024 Earnings Call Transcript May 6, 2024 BioCryst Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.31 EPS, expectations were $-0.23. BCRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, and welcome […]

  • GlobeNewswire

    BioCryst to Present at Upcoming Investor Conferences

    RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following conferences: Citizens JMP Life Sciences Conference in New York on Monday, May 13, 2024, at 12:30 p.m. ET. 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024, at 3:05 p.m. ET. Bank of America Health Care Conference 2024 in Las Vegas on Wednesday, May 15, 2024, at 5:20 p.m. ET. H.C. Wainwr

  • Simply Wall St.

    BioCryst Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations

    BioCryst Pharmaceuticals ( NASDAQ:BCRX ) First Quarter 2024 Results Key Financial Results Revenue: US$92.8m (up 35...